Malignant Musculoskeletal Neoplasm — Trials

Malignant Musculoskeletal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

465 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 141
Recruiting: 73
Ph III recruiting: 6
Growth YoY: −28%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (58)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05057130	Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors	unknown	Phase 2 / Phase 3	50	Blokhin's Russian Cancer Research CenterOTHER	1	Apr 1, 2024	clinicaltrials
NCT04842071	18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment	unknown	Phase 3	2,500	Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER	1	Feb 7, 2024